Application Notes

Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

Issue link: https://resources.nanotempertech.com/i/1050500

Contents of this Issue

Navigation

Page 4 of 5

5 APPLICATION NOTE ©2017 NanoTemper Technologies, Inc. South San Francisco, CA, USA. All Rights Reserved. sample were filled into 3 nanoDSF Grade Standard Capillaries (NanoTemper Technologies), respectively, and loaded into the instrument. mAb thermal unfolding was monitored in a 1 °C/min thermal ramp from 20 °C to 95 °C. T m values were determined automatically by the PR.Control so ware. µDSC thermal unfolding Differential scanning calorimetry experiments were performed on a MicroCal Auto VP-Capillary DSC System (Malvern Instruments). For the measurements about 400 µl sample was required. To determine the background, reference and sample cell were filled with formulation buffer and scanned from 10 °C to 100 °C with a scan rate of 1 °C/min. To determine the T m of the protein, the sample cell was filled with the protein solution and the reference cell with formulation buffer, and one heating scan from 10 °C to 100 °C at 1 °C/min was performed. A er the protein scan, the cells were filled with 10 % Decon 90 solution and scanned with the same settings of the protein sample. Subsequently, the cells were washed extensively with highly purified water to remove the detergent. The background obtained from the corresponding formulation buffer scan was subtracted from the sample measurement. The T m values were determined from the peak maxima of the unfolding transitions a er baseline subtraction. Data analysis was performed by using the system's Origin 7.0 DSC so ware. Material and Methods Protein preparation A therapeutic IgG1-type mAb was dialyzed into the formulation buffers listed in Table 1. The protein concentration was adjusted to ca. 1 mg /ml. nanoDSF thermal unfolding Thermal protein unfolding was monitored using the Prometheus NT.48 instrument (NanoTemper Technologies). For each buffer condition, 30 µl a 1 mg /ml mAb solution was prepared, and ~10 µl of Table 1: List of formulation buffers. Buffer substance 20 mM Acetate 20 mM Acetate 20 mM Acetate 20 mM Histidine 20 mM Histidine 20 mM Histidine 20 mM Phosphate 20 mM Phosphate 20 mM Histidine 20 mM Histidine pH 3.0 4.0 5.0 5.0 6.0 7.0 7.0 8.0 6.0 6.0 Additive 0.02% PS20 0.02% PS80

Articles in this issue

view archives of Application Notes - Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development